亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions—Comparison with Sole Drug–coated Balloon Revascularization: Two-year Outcomes

医学 血管成形术 气球 跛行 腘动脉 外科 血运重建 动脉切除术 血管造影 病变 间歇性跛行 放射科 截肢 严重肢体缺血 再狭窄 血管疾病 动脉疾病 支架 内科学 心肌梗塞
作者
Orhan Rodoplu,Didem Melis Öztaş,Mert Meriç,Metin Onur Beyaz,Mustafa Özer Ulukan,Cenk Eray Yıldız,Orçun Ünal,Murat Uğurlucan
出处
期刊:Annals of Vascular Surgery [Elsevier BV]
卷期号:73: 222-233 被引量:11
标识
DOI:10.1016/j.avsg.2020.10.051
摘要

We aimed to evaluate the results of the combined use of rotational atherectomy (RA) followed by drug-coated balloon (DCB) treatment against DCB angioplasty alone in patients who had significantly calcified and symptomatic femoropopliteal peripheral arterial disease.Patients presented to the clinic with symptoms of chronic limb ischemia of femoropopliteal segment such as moderate or severe claudication and rest pain, who received endovascular therapy between January 2016 and January 2018 in our hospital comprised the study cohort and investigated, retrospectively. Patients with minor or major tissue loss were excluded from the study. We evaluated the effect of RA system followed by DCB with DCB alone in 121 patients and a total of 226 significantly calcified and symptomatic femoropopliteal lesions. Fifty-eight patients and 112 (49.5%) lesions were treated with RA + DCB, whereas 63 patients and 114 (50.5%) lesions were treated with DCB only. The mean age was 61.2 ± 9.7 years. Primary patency is evaluated with duplex ultrasound/angiography at 6, 12, and 24 months and with angiography on 12 and 24 months. Patients were followed up for 24 months to assign clinically driven target lesion revascularization (TLR). Overall survival rates were 96.5% (56/58) in RA + DCB group and 93.6% (59/63) in DCB alone group both at one-year and two-year follow-up. Amputation-free survival rates of RA + DCB and DCB-only groups are 96.5% (56/58) to 87.3% (55/63) at one year, and 94.8% (55/58) to 82.5% (52/63) at two years, respectively.Baseline characteristics of groups were similar. The lesions were longer in the RA + DCB group than the DCB alone group (14.4 ± 5.2 cm vs. 10.2 ± 3.1 cm; P = 0.05). The technical success rate in the RA + DCB group was superior to that of DCB-only group (95.4% vs. 84.8%, P = 0.006). The 12-month and 24-month patency rates with angiography in the RA-DCB group were similar to those in the DCB-only group (85.7% vs. 74.6% and 73.2% vs. 62.7%, respectively). The rates of bailout stenting were significantly lower among patients treated with RA + DCB (n = 3; 5.1% vs. n = 13; 20.6%, P < 0.001). The rates of flow-limiting dissections and vessel recoils after procedures were significantly in RA + DCB group (n = 2; 3.4% vs. n = 8; 12.6%, P < 0.001) than DCB only (n = 1; 1.7% vs. n = 4; 6.3%, P < 0.002). The freedom from TLR rate was significantly increased in the RA + DCB group at 12 months (95.2% vs. 76.3%, P = 0.002) and 24 months (93.4% vs. 63.7%, P = 0.002). The mean ankle brachial index at discharge in the RA-DCB group improved by 0.35 ± 0.24, and in the DCB-only group, it was 0.30 ± 0.23 (P = 0.683).Combined use of RA and DCB treatment is an effective, safe, and durable method for the treatment of the complex femoropopliteal lesions. Combination of RA and DCB angioplasty reveals increased technical success, fewer flow-limiting dissections, significantly reduced TLR, and bailout stenting rates compared with sole DCB angioplasty.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雨落瑾年完成签到,获得积分0
8秒前
lin完成签到,获得积分10
8秒前
Glufo完成签到,获得积分10
10秒前
俏皮的灵完成签到,获得积分10
10秒前
12秒前
臭学医的完成签到 ,获得积分10
13秒前
大溺完成签到 ,获得积分10
16秒前
传奇3的应助被DRJ采纳,获得10
20秒前
思源的应助被雪山大地采纳,获得10
20秒前
22秒前
Aixx完成签到 ,获得积分10
26秒前
可靠友梅完成签到,获得积分10
27秒前
YU完成签到,获得积分10
31秒前
Leowo完成签到,获得积分10
31秒前
和谐以冬完成签到,获得积分10
33秒前
35秒前
深情安青的应助被Qiaoguliang采纳,获得10
36秒前
36秒前
Moooi完成签到,获得积分10
39秒前
40秒前
莫里亚蒂完成签到,获得积分10
43秒前
Charlie完成签到 ,获得积分10
44秒前
Yu完成签到 ,获得积分10
45秒前
可爱的函函的应助被DRJ采纳,获得10
46秒前
47秒前
50秒前
51秒前
莫里亚蒂完成签到,获得积分10
52秒前
52秒前
Ch发布了新的文献求助10
54秒前
NexusExplorer的应助被wstki采纳,获得10
54秒前
哈哈哈哈发布了新的文献求助10
55秒前
56秒前
57秒前
高分子聚合绿豆汤完成签到 ,获得积分10
57秒前
勤奋柜子的应助被雪山大地采纳,获得10
58秒前
Ahloe发布了新的文献求助10
59秒前
JohnYoung发布了新的文献求助10
1分钟前
小巧孤兰完成签到,获得积分10
1分钟前
礼拜一发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165776
求助须知:如何正确求助?哪些是违规求助? 9559273
关于积分的说明 21749731
捐赠科研通 7756580
什么是DOI,文献DOI怎么找? 3429034
关于科研通互助平台的介绍 2553319
邀请新用户注册赠送积分活动 2473606